Turning science into business: AnĀ optimised alternative to antibodies
Drug Discovery World
APRIL 3, 2023
As life science operates globally, the vision for the business was always to bring aptamers as an antibody alternative to researchers worldwide. Beyond direct conjugation of therapeutic molecules for delivery, our aptamers can also be conjugated to larger vectors for use in precision medicines.
Let's personalize your content